Shuangjia Wang

Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma

Ruiqi Liu, Yuejin Li, Lantian Tian et al. · Cancer Letters · 2018 · 144 citations

Medicine, Cancer Biology, Oncology +16

Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer

Yizhen Pang, Long Zhao, Qihang Shang et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 101 citations

Medicine, Nuclear Medicine, Oncology +15

Nuclear Factor-κB–Dependent Epithelial to Mesenchymal Transition Induced by HIF-1α Activation in Pancreatic Cancer Cells under Hypoxic Conditions

Zhuoxin Cheng, Bei Sun, Shuangjia Wang et al. · PLoS ONE · 2011 · 86 citations · Full text

Medicine, Cancer Biology, Oncology +17

Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway

Shuangjia Wang, Bei Sun, Zhuoxin Cheng et al. · Cancer Chemotherapy and Pharmacology · 2011 · 85 citations

Medicine, Oncology, Pharmacology +14

Downregulation of nuclear factor-κB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer

Rui Kong, Bei Sun, Hongchi Jiang et al. · Cancer Letters · 2009 · 80 citations

Medicine, Molecular Biology, Oncology +11